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Summary
 Aim To analyse (quantitatively-statistically) conformity indices calculated for stereo-
tactic radiosurgery treatment plans with one and two isocentres in cases of brain 
tumour.
 Materials/Methods A retrospective study of 33 patients with brain tumours treated between April 
2005 and January 2006 was performed in the Radiotherapy Department of the 
Oncology Centre in Łódź. Stereotactic surgery was performed in all patients. All 
treatment plans were divided into two groups: plans with one isocentre and plans 
with two isocentres. For each treatment plan various kinds of conformity param-
eters were calculated and optimal prescription isodose level was determined.
 Results All conformity indices are within ranges and were accepted. Their values are low-
er in plans with two isocentres in comparison to plans with one isocentre.
 Conclusions Conformity indices are very helpful in the analysis of treatment plans, but they 
do not give real insight into all aspects of plans. Prescription isodose should com-
pletely enclose PTV volume. Optimal prescription isodose does not cover PTV; 
thus from a clinical point of view it is inapplicable.
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BACKGROUND
Recent years have witnessed very dynamic devel-
opment of many treatment techniques using ion-
ising radiation. The most often employed treat-
ment techniques, especially in brain tumours, 
are stereotactic radiosurgery (SRS) and stereo-
tactic radiotherapy (SRT). These two techniques 
include irradiation of very small lesions in the 
brain using many static photon beams. Dose ac-
cumulated in the tumour can be delivered in one 
fraction (SRS) or in many fractions (SRT). To 
be able to utilise this technique it is necessary to 
have a stereotactic frame with instrumentation, 
multileaf collimator and treatment planning sys-
tem (TPS). The planning system together with 
computer tomography images and magnetic res-
onance images allow one to plan in a very pre-
cise manner the arrangement of photon beams 
in relation to reference markers.
The primary aim in planning stereotactic radio-
surgery is high homogeneity of dose in the PTV 
volume and steep gradient of dose in healthy 
tissues. However, this is very difﬁ cult to achieve 
in cases where there are organs at risk near the 
PTV volume which should receive the lowest pos-
sible dose. It is especially important as many le-
sions, which are located in different parts of the 
brain, are simultaneously irradiated. Then the 
probability of adverse overdose formation in nor-
mal tissues increases. Proper preparation of the 
treatment plan requires very great precision. It 
involves both very precise ﬁ tting of the leaves of 
the multileaf collimator to the PTV volume and 
also very precise ﬁ tting to the PTV volume pre-
scription isodose, which should to a lesser degree 
cover normal tissues.
Every treatment plan should be subjected to ver-
iﬁ cation. First of all the recommended dose and 
prescription isodose and then isodose distribution 
slice-by-slice should be checked. A dose volume 
histogram for every organ at risk and PTV is a very 
important part of the treatment plan. Exact analy-
sis of this histogram allows one to ﬁ nd dangerous 
overdosage to the organ at risk and unacceptable 
underdose to PTV. Knowing this, correction of 
the plan should be made. Additionally, for every 
treatment plan conformity parameters, which de-
ﬁ ne its quality, should be calculated [1–7].
AIM
The main aim is the comparative analysis (quan-
titatively-statistically) of conformity indices 
calculated for plans with one and two isocen-
tres. By calculation of many parameters for many 
plans in a simple way we can compare them and 
make deductions. Then it will help to improve 
planning and treatment.
MATERIALS AND METHODS
Many parameters deﬁ ning plan conformity should 
be calculated for every stereotactic radiosurgery 
plan for the brain. One of two fundamental in-
dices is the Conformation Number (CN) [2,12], 
which is given by the following equation: 
CN =
 PTVPI · PTVPI (1)           VPI · PTV
where: PTVPI is the PTV volume which is irradiat-
ed with prescription isodose (PI), VPI is the total 
volume of tissue which is irradiated with prescrip-
tion isodose (PI), PTV is the volume of PTV, PTV 
is the planning target volume.
This index is a combination of two others indices. 
The ﬁ rst was introduced in 1993 by the Radiation 
Therapy Oncology Group [1,12] – Conformity 
Index (PITV), expressed by following equation: 
PITV = VPI (2)
           PTVPI
This parameter determines the overdosed vol-
ume of normal tissues. In most cases its value is 
above 1.0 because prescription isodose covers not 
only PTV but also a small volume of normal tissue 
around PTV. In the ideal plan this parameter is 
equal to 1.0; however, in most plans it is between 
1.0 and 2.0, which is acceptable and in agreement 
with the procedure. Every other value above or 
below this range implies low conformity of the 
plan and requires comprehensive analysis.
The other index is the Volume-Related Target 
Coverage (vTC) [8,12], which is expressed as: 
vTC = 
PTVPI (3)
          PTV
It is the ratio of PTV volume enclosed by prescrip-
tion isodose to total PTV volume. This parameter 
represents PTV volume with underdose. Its theo-
retical value is in the range of 0.0–1.0 but accept-
able values are in the range of 0.8–1.0.
By precise analysis of both parameters it can be 
found that the value of CN represents volume with 
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an overdose to normal tissues and underdose to 
PTV. Its ideal value is 1.0 and values from 0.0 to 
0.5 indicate the low conformity of the plan.
The second important parameter quantitatively de-
scribing the plan is the Dose-Related Conformation 
Number (dCN) [12], which is expressed as: 
dCN =
 PTVPI · PTVPI · Dmin (4)                 VPI · PTV · PI
It is a combination of the Conformation Number 
(CN) and the Dose-Related Target Coverage 
(dTC) [12]:
dTC = 
Dmin (5)              PI
where Dmin is the minimum dose in PTV.
The dTC parameter represents the volume of PTV 
with a dose much higher than the prescription 
isodose and does not represent the volume of PTV 
where there is an underdosage. Its optimum val-
ue is 1.0. It is fulﬁ lled when prescription isodose 
fully encloses PTV. But in other cases when PTV 
is not completely enclosed by this isodose, its val-
ue will be lower than 1.0. A reasonable range for 
this parameter is from 0.9 to 1.0.
The dCN parameter describes quantitatively the 
same aspects as CN does and gives information 
about the overdosed volume of PTV which indi-
cates the gradient in this volume. The accepta-
ble value is 1.0 and every lower value shows de-
viation from the plan.
Over the last six months in the Radiotherapy 
Department of the Oncology Centre in Łódź pa-
tients with small brain tumours have been treat-
ed using stereotactic radiosurgery. This method 
was applied to 15 patients with metastatic tu-
mours and to 18 patients with primary tumours. 
An immobilizing mask, made of thermoplastic 
material, was prepared for every patient before 
treatment. Computer tomography images were 
taken with step of 2mm. Additionally, when any 
problems with delineation of PTV occurred, im-
ages using nuclear magnetic resonance (NMR) 
were recorded. A series of images from CT and 
NMR superimposed in TPS made deﬁ nition of 
PTV easier. Every treatment plan was prepared 
using the BrainScan planning system (BrainLab, 
Munich Germany). Varian 600D linac with mul-
tileaf microcollimator m3 from BrainLab and 
stereotactic frame for exact patient positioning 
were applied. Only patients with one or two tu-
mours were treated (maximum of 2 isocentres 
were used). For every treatment plan many pa-
rameters (vTC, dTC, CLx, CN, dCN) were calcu-
lated and together with comprehensive veriﬁ ca-
tion of DVH’s and dose distributions they make 
the plan acceptable or not.
Optimal prescription isodose
Every treatment plan of stereotactic radiosurgery 
prepared in the Regional Oncology Centre in 
Łódź was analysed mathematically. For every isod-
ose from 80% to 100% parameters of conform-
ity indices were calculated (CN, dCN). Figure 1 
shows parameters’ value as a function of isod-
ose. The curve in this ﬁ gure has a characteristic 
maximum, and the isodose that is responsible 
for this maximum does not enclose any normal 
tissues, has the highest values of conformity pa-
rameters and mathematically is the best prescrip-
tion isodose.
RESULTS
A retrospective analysis of 33 patients with 
brain tumours treated between April 2005 and 
January 2006 was performed in the Radiotherapy 
Department of the Oncology Centre in Łódź. 
Stereotactic surgery was performed in all pa-
tients. All treatment plans were divided into two 
groups: plans with one isocentre and plans with 
two isocentres.
For every single isocentre 6 to 8 static photon 
beams were used. The treatment technique de-
pended on size of the tumour and its location 
in relation to the organ at risk [9,10]. The pre-
scribed dose for PTV was 10–20Gy for prescrip-
tion 80% isodose and was dependent on size of 
the tumour. The 80% isodose had to cover min-
imum 99.5% of PTV.
The main parameters that helped to determine 
the optimal prescription isodose were CN and 
dCN. For 80% isodose for one isocentre values 
of CN were between 0.51 and 0.80 (average 0.66) 
and values of dCN were between 0.47 and 0.70 
(average 0.64). Optimal prescription isodoses 
evaluated on the basis of CN and dCN were be-
tween 86% and 92% and for them the value of 
CN was 0.68 to 0.94 (average 0.80) and the value 
of dCN was 0.62 to 0.93 (average 0.77). The PTV 
volume was enclosed by 80% isodose in 99.88% 
and 92.33% of PTV volume was enclosed by op-
timal prescribed isodose.
Rep Pract Oncol Radiother, 2006; 11(4): 197-204 Biegała M et al – Comparative analysis of stereotactic radiosurgery treatment…
199
1.00
0.80
0.60
0.40
0.20
0.00
Co
eﬃ
cie
nt
s
79                81              83               85                87              89               91              93                95                97              99             101
Prescribe isodose [%]
dCN
CN
Figure 1. Example graph of a dependence coeffi  cient to isodoses.
No PTV volume [cm3]
Prescribed 
isodose [%]
Optimal
isodose [%]
Percent PTV 
volume [%] VTC dTC CLx CN dCN
1 2.02
80  100.00 1.00 1.00 0.58 0.58 0.58
 87 96.16 0.96 1.00 0.84 0.81 0.81
2 5.24
80  99.91 1.00 0.99 0.64 0.64 0.63
 88 94.75 0.95 0.99 0.83 0.79 0.78
3 13.78
80  99.94 1.00 1.00 0.75 0.75 0.75
 91 87.75 0.88 1.00 0.94 0.82 0.82
4 27.38
80  99.91 1.00 1.00 0.70 0.70 0.70
 89 96.61 0.97 1.00 0.85 0.82 0.82
5 6.98
80  99.90 1.00 0.99 0.64 0.64 0.63
 90 91.54 0.92 0.99 0.86 0.78 0.77
6 2.20
80  99.80 1.00 0.98 0.65 0.65 0.63
 87 95.41 0.95 0.98 0.84 0.80 0.78
7 30.73
80  99.95 1.00 0.95 0.67 0.67 0.63
 91 94.04 0.94 0.95 0.83 0.78 0.74
8 44.14
80  99.93 1.00 0.93 0.72 0.72 0.67
 92 92.70 0.93 0.93 0.89 0.82 0.76
Table 1. Analysis coeffi  cients for plans with one isocentre.
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No PTV volume [cm3]
Prescribed 
isodose [%]
Optimal
isodose [%]
Percent PTV 
volume [%] VTC dTC CLx CN dCN
9 1.31
80  99.80 1.00 0.91 0.51 0.51 0.47
 90 83.52 0.84 0.91 0.82 0.68 0.62
10 6.42
80  99.91 1.00 0.99 0.73 0.73 0.72
 88 88.65 0.89 0.99 0.87 0.77 0.76
11 5.00
80  99.72 0.99 0.96 0.62 0.61 0.59
 87 93.91 0.94 0.96 0.77 0.72 0.70
12 5.45
80  99.50 0.69 0.90 0.65 0.45 0.40
 89 92.92 0.64 0.90 0.84 0.54 0.49
13 11.96
80  100.00 1.00 1.00 0.75 0.75 0.75
 90 98.83 0.90 1.00 0.92 0.82 0.82
14 12.70
80  99.81 1.00 0.90 0.62 0.62 0.55
 91 91.94 0.92 0.90 0.85 0.78 0.70
15 1.37
80  99.90 1.00 1.00 0.55 0.55 0.55
 88 90.49 0.90 1.00 0.82 0.74 0.74
16 24.06
80  99.83 1.00 0.93 0.63 0.63 0.58
 90 97.64 0.97 0.93 0.81 0.78 0.72
17 1.47
80  99.93 1.00 0.99 0.80 0.80 0.79
 86 93.67 0.94 0.99 1.00 0.94 0.93
18 6.75
80  99.94 1.00 0.98 0.68 0.68 0.67
 89 93.83 0.94 0.98 0.88 0.82 0.80
19 1.84
80  99.73 1.00 0.94 0.70 0.70 0.66
 88 85.64 0.86 0.94 1.00 0.86 0.80
20 3.39
80  99.90 1.00 0.95 0.66 0.66 0.62
 91 80.20 0.80 0.95 1.00 0.80 0.76
21 5.71
80  100.00 1.00 1.00 0.63 0.63 0.63
 87 96.22 0.96 1.00 0.83 0.80 0.80
22 21.64
80  99.96 1.00 0.99 0.70 0.70 0.69
 90 94.86 0.95 0.99 0.86 0.82 0.81
23 9.52
80  99.98 1.00 0.99 0.68 0.68 0.67
 90 93.70 0.94 0.99 0.90 0.84 0.83
Table 1 cont. Analysis coeffi  cients for plans with one isocentre.
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No PTV volume [cm3]
Prescribed 
isodose [%]
Optimal
isodose [%]
Percent PTV 
volume [%] vTC dTC CLx CN dCN
1
11.18
80  99.71 1.00 0.95 0.65 0.65 0.62
 93 87.40 0.87 0.95 0.90 0.78 0.74
1.30
80  99.79 1.00 0.96 0.63 0.63 0.61
 88 90.96 0.91 0.96 1.00 0.91 0.88
2
31.18
80  99.82 1.00 0.95 0.69 0.69 0.66
 91 93.76 0.94 0.95 0.87 0.82 0.78
7.87
80  99.78 0.99 0.93 0.75 0.74 0.69
 88 88.92 0.89 0.93 0.89 0.79 0.73
3
5.53
80  99.82 1.00 1.00 0.67 0.67 0.67
 86 94.76 0.95 1.00 0.80 0.75 0.75
17.69
80  99.77 1.00 0.96 0.68 0.68 0.65
 91 90.37 0.90 0.96 0.86 0.77 0.75
4
34.21
80  99.91 1.00 0.94 0.61 0.61 0.57
 91 89.71 0.90 0.94 0.76 0.68 0.64
4.30
80  99.90 1.00 1.00 0.63 0.63 0.63
 91 85.03 0.85 1.00 0.91 0.77 0.77
5
8.25
80  99.35 0.98 0.86 0.63 0.62 0.53
 92 81.96 0.82 0.86 0.84 0.69 0.59
22.42
80  99.56 0.99 0.94 0.53 0.53 0.49
 94 84.80 0.85 0.94 0.78 0.66 0.62
6
5.71
80  100.00 1.00 1.00 0.63 0.63 0.63
 87 96.22 0.96 1.00 0.83 0.80 0.80
24.06
80  99.83 1.00 0.91 0.63 0.63 0.57
 90 95.51 0.97 0.91 0.81 0.78 0.71
7
3.39
80  99.90 1.00 0.95 0.66 0.66 0.62
 91 90.50 0.80 0.95 1.00 0.80 0.76
19.29
80  100.00 1.00 1.00 0.73 0.73 0.73
 87 95.35 0.97 1.00 0.82 0.80 0.80
8
8.26
80  99.81 1.00 0.98 0.87 0.87 0.85
 87 95.74 0.96 0.98 0.94 0.90 0.88
1.01
80  100.00 1.00 1.06 0.58 0.58 0.62
 88 95.52 1.00 1.06 0.73 0.73 0.77
9
1.45
80  99.87 0.99 0.96 0.56 0.55 0.53
 87 90.87 0.94 0.96 0.83 0.78 0.75
6.43
80  99.41 0.99 0.93 0.71 0.71 0.66
 89 90.89 0.93 0.93 0.91 0.85 0.79
10
8.07
80  100.00 1.00 1.00 0.72 0.72 0.72
 87 96.20 0.96 1.00 0.84 0.81 0.81
1.39
80  100.00 1.00 1.00 0.61 0.61 0.61
 90 95.43 0.95 1.00 0.80 0.76 0.76
Table 2. Analysis coeffi  cients for plans with two isocentres.
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In the case of two isocentres for isodose 80% val-
ues of CN were between 0.53 and 0.87 (average 
0.65) and values of dCN were between 0.49 and 
0.85 (average 0.63). Optimal prescribed isodoses 
evaluated on the basis on CN and dCN were be-
tween 86% and 94% and values of CN and dCN 
related to them were between 0.66 and 0.91 (av-
erage 0.78) and 0.59 and 0.88 (average 0.75) re-
spectively. The PTV volume was enclosed by 80% 
isodose in 99.76% and 91.49% was enclosed by 
optimal prescription isodose.
Performing comparative analysis of plans with 
one and two isocentres one ﬁ nds that the aver-
age values of parameters CN and dCN are high-
er for plans with one isocentre by about 0.35% 
(p=0.925) and 0.15% (p=0.970) for 80% isod-
ose, respectively and 0.88% (p=0.750) and 1.3% 
(p=0.686) higher for optimal isodose. The aver-
age percentage value of PTV volume covered by 
80% is higher by about 0.07% (p=0.946) and cov-
ered by optimal isodose is higher by about 0.97 
(p=0.513) for plans with one isocentre.
Analysis of results
In comparative analysis of conformity parameters 
for plans with one and two isocentres Student’s 
t-test [11] was used. On its basis one can ﬁ nd 
differences between two groups of plans (one 
and two isocentres). For analysis level of signiﬁ -
cance was set at a=0.05. For every analysis for eve-
ry group level of probability p was calculated. All 
values a<p show us that these two groups do not 
differ signiﬁ cantly. In all cases described above 
the level of signiﬁ cance a is lower than the lev-
el of probability p.
Tables 1 and 2 show whole volume of PTV togeth-
er with parameters of conformity and values of 
optimal isodose and percentage volume of PTV 
covered by this isodose. A detailed analysis of 
PTV volume and value of optimal isodose does 
not show any correlation between these quanti-
ties [11]. For plans with one isocentre the val-
ue of the correlation parameter is R2=0.40 and 
for plans with two isocentres is R2=0.18. There is 
also no direct dependence between the value of 
the PTV volume and the correlation parameters 
which are near zero.
The value of conformity parameters and value 
of the optimal isodose depend on the value of 
volume of normal tissues covered by the opti-
mal isodose. Outline of the PTV volume and its 
position in relation to the organ at risk have a 
great inﬂ uence on these values. It is known that 
when the PTV volume is more irregular and po-
sitioned close to organs at risk or a second tu-
mour it is more difﬁ cult to set the number of 
ﬁ elds to provide optimal values of conformity 
parameters. In such a case there is a high pos-
sibility of overdosage in normal tissues, which 
is a problem when making a plan and affects 
values of conformity parameters. In the above-
mentioned analysis all parameters for plans with 
two isocentres have lower values than in plans 
with one isocentre. For plans with one isocen-
tre we have much more freedom in setting the 
ﬁ elds because there is no second tumour. But it 
does not mean that conformity parameters cal-
culated for treatment isodose can differ signiﬁ -
cantly in these two groups. Differences for this 
isodose are low: 0.35% and 0.15% respectively. 
Noticeable differences between plans with one 
and two isocentres can be noticed for conform-
ity parameters calculated for optimal isodose. 
This is natural because a large number of ﬁ elds 
in plans with two isocentres and limits in setting 
them increase the probability of irradiation of a 
larger volume of normal tissues and of covering 
minimum 99.5% PTV volume by treatment isod-
ose (the difference in coverage of PTV volume 
by treatment isodose between the two plans is 
minimal and is 0.07%). As was stated above the 
value of optimal isodose and parameters calcu-
lated for it essentially depend on the volume of 
normal tissues irradiated by treatment isodose. 
This means that differences between plans for 
optimal isodose are higher than for treatment 
isodose, being 0.88% and 1.3%.
CONCLUSIONS
The determination of conformity indices for eve-
ry plan is a routine operation performed at the 
end of treatment planning and before ﬁ nal au-
dit by a physician. However, it gives us informa-
tion only about the present, and not what could 
cause problems. Making any decisions concern-
ing the plan relying only on mathematical param-
eters can result in fundamental faults. Only an 
overall view of all aspects of the plan can guar-
antee correct realization. It is the main policy in 
safe treatment course. Not all plans with param-
eters below acceptance level are unacceptable. 
In some cases, although its value is not reasona-
ble, the plan is accepted because of other impor-
tant facts (clinical, ethical). Prescription isodose 
should be changed as a logical consequence of 
the aforementioned analysis and in particular the 
determination of optimal prescription isodose. 
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From a mathematical point of view it is reasona-
ble because values of conformity parameters for 
many but not all isodoses above 80% are high-
er than those for 80% isodose. Assigning dose to 
optimal prescription isodose leads to better out-
put in conformity parameters for every plan and 
makes the dose lower at the isocentre point which 
is normalized to 100%. This approach is mathe-
matically correct but does not meet criteria for 
enclosing 99.5% volume of PTV by prescription 
isodose. The average volume of PTV enclosed by 
optimal prescription isodose in plans is 91.9% and 
88.8% with one isocentre and with two isocen-
tres, respectively. This means that about 10% of 
PTV volume is underdosed, which cannot be ac-
cepted in stereotactic radiosurgery because this 
failure will not be possible to rearrange. Such so-
phisticated and exact analysis of every plan is a 
major part of quality assurance. It allows for fast 
and convenient comparison of plans prepared us-
ing different stereotactic techniques and in differ-
ent oncology centres. It is very useful and ensures 
high quality assurance and steady improvement 
in planning. Meticulous analysis of the dose dis-
tribution in every image and the dose volume 
histogram of PTV and organs at risk are crucial 
parts of the planning process. They can guaran-
tee successful treatment through eliminating the 
possibility of irreversible mistakes.
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